October 21, 2022 October 21, 2022Categories Press ReleasesPress Release: Head and neck cancer researchers demonstrate the capability of a deep learning algorithm in the post-surgery setting to assess the stage of disease more accurately using standard CT scans
October 20, 2022 October 20, 2022Categories Announcements Press ReleasesPress Release: ECOG-ACRIN taps the University of Pennsylvania’s Selina Luger to lead its Leukemia Committee
September 27, 2022 September 27, 2022Categories Press ReleasesMedia Advisory: Journal of Clinical Oncology publishes outcomes from the practice-changing DREAMseq trial in patients with advanced melanoma
September 8, 2022 September 8, 2022Categories Press ReleasesPress Release: ECOG-ACRIN completes the first randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer
July 14, 2022 July 14, 2022Categories Press ReleasesMedia Advisory: Blood publishes long-term outcomes of patients with CLL in the practice-changing E1912 trial
May 27, 2022 May 27, 2022Categories Press ReleasesPress Release: ECOG-ACRIN research highlights at ASCO 2022
May 17, 2022 May 17, 2022Categories Press ReleasesMedia Advisory: ECOG-ACRIN data at ASCO will showcase the Group’s robust research portfolio
March 25, 2022 March 25, 2022Categories Press ReleasesPress Release: Enrollment in TMIST breast cancer screening trial surpasses halfway mark; recruitment of women from diverse backgrounds is key to success
March 16, 2022 March 16, 2022Categories Press ReleasesPress Release: ECOG-ACRIN opens a new NCI-MATCH treatment arm for dMMR and LAG-3-positive cancers as it continues to locate patients with BRAF mutations
